Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Corey

Showing results (481-490 of 511) with videos related to

Pageof 52
Sort By:
Blood|December 10, 1999
Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantationL A Holmberg, M Boeckh, H Hooper, et al.
Journal of Virology|April 29, 1998
Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infectionS J Polyak, S McArdle, S L Liu, et al.
Nature Medicine|March 21, 1998
Evolutionary pattern of human immunodeficiency virus (HIV) replication and distribution in lymph nodes following primary infection: implications for antiviral therapyG Pantaleo, O J Cohen, T Schacker, et al.
AIDS (London, England)|February 1, 1988
Genital ulceration as a risk factor for human immunodeficiency virus infectionR M Greenblatt, S A Lukehart, F A Plummer, et al.
Clinical Transplantation|March 18, 2014
Vitamin D deficiency, parathyroid hormone levels, and bone disease among patients with end-stage liver disease and normal serum creatinine awaiting liver transplantationRebecca L Corey, Michael D Whitaker, Michael D Crowell, et al.
AIDS Research and Human Retroviruses|February 24, 1999
HIV-1MN recombinant glycoprotein 160 vaccine-induced cellular and humoral immunity boosted by HIV-1MN recombinant glycoprotein 120 vaccine. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation GroupG J Gorse, L Corey, G B Patel, et al.
The Journal of Infectious Diseases|February 18, 1998
Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and bloodR W Coombs, C E Speck, J P Hughes, et al.
Journal of Clinical Microbiology|April 16, 1999
Multicenter comparison of PCR assays for detection of human herpesvirus 8 DNA in semenP E Pellett, T J Spira, O Bagasra, et al.
Annals of Internal Medicine|October 15, 1993
Combination therapy with zidovudine and didanosine compared with zidovudine alone in HIV-1 infectionA C Collier, R W Coombs, M A Fischl, et al.
AIDS Research and Human Retroviruses|May 20, 1996
Safety and immunogenicity of Env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59. NIAID AIDS Vaccine Evaluation GroupM C Keefer, B S Graham, M J McElrath, et al.
Pageof 52

Showing results (481-490 of 511) with videos related to

Sort By:
Pageof 52
Blood|December 10, 1999
Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantationL A Holmberg, M Boeckh, H Hooper, et al.
Journal of Virology|April 29, 1998
Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infectionS J Polyak, S McArdle, S L Liu, et al.
Nature Medicine|March 21, 1998
Evolutionary pattern of human immunodeficiency virus (HIV) replication and distribution in lymph nodes following primary infection: implications for antiviral therapyG Pantaleo, O J Cohen, T Schacker, et al.
AIDS (London, England)|February 1, 1988
Genital ulceration as a risk factor for human immunodeficiency virus infectionR M Greenblatt, S A Lukehart, F A Plummer, et al.
Clinical Transplantation|March 18, 2014
Vitamin D deficiency, parathyroid hormone levels, and bone disease among patients with end-stage liver disease and normal serum creatinine awaiting liver transplantationRebecca L Corey, Michael D Whitaker, Michael D Crowell, et al.
AIDS Research and Human Retroviruses|February 24, 1999
HIV-1MN recombinant glycoprotein 160 vaccine-induced cellular and humoral immunity boosted by HIV-1MN recombinant glycoprotein 120 vaccine. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation GroupG J Gorse, L Corey, G B Patel, et al.
The Journal of Infectious Diseases|February 18, 1998
Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and bloodR W Coombs, C E Speck, J P Hughes, et al.
Journal of Clinical Microbiology|April 16, 1999
Multicenter comparison of PCR assays for detection of human herpesvirus 8 DNA in semenP E Pellett, T J Spira, O Bagasra, et al.
Annals of Internal Medicine|October 15, 1993
Combination therapy with zidovudine and didanosine compared with zidovudine alone in HIV-1 infectionA C Collier, R W Coombs, M A Fischl, et al.
AIDS Research and Human Retroviruses|May 20, 1996
Safety and immunogenicity of Env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59. NIAID AIDS Vaccine Evaluation GroupM C Keefer, B S Graham, M J McElrath, et al.
Pageof 52